Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.61 |
| ▸ | TTR | P02766 | 3/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.61 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | ABL1 | P00519 | 2/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | BCR | P11274 | 2/20 | 0.61 |
| ▸ | NQO2 | P16083 | 2/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | GFER | P55789 | 2/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2521181 | 1.00 | CYP1A1 (0.61) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2513436 | 0.95 | CYP1A1 (0.65) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2513437 | 0.95 | CYP1A1 (0.65) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2516448 | 0.89 | KDM4E (0.62) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2516451 | 0.89 | KDM4E (0.62) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2516557 | 0.89 | ESR1 (0.53) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL13253647 | 0.88 | LTA4H (0.57) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2516475 | 0.85 | KDM4E (0.61) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL2516476 | 0.85 | KDM4E (0.61) | CYP1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL16280741 | 0.82 | LTA4H (0.86) | MEN1KMT2APTGS2NPC1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9861564-B2 | Valeric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT, LLC (US) | 2018-01-09 | — | — | US | disclosed |
| US-9782335-B2 | Malic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-10-20 | — | — | US | disclosed |
| EP-2445511-B1 | SKIN REPAIR COMPOSITIONS COMPRISING CIRCADIAN GENE ACTIVATORS AND A SYNERGISTIC COMBINATION OF SIRT1 GENE ACTIVATORS | ELC MAN LLC (US) | 2016-09-07 | — | — | EP | disclosed |
| US-20160229791-A1 | Malic Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-08-11 | — | — | US | disclosed |
| US-9358194-B2 | Succinic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2016-06-07 | — | — | US | disclosed |
| US-9295621-B2 | Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant | ELC MANAGEMENT LLC (US) | 2016-03-29 | — | — | US | disclosed |
| US-20160038389-A1 | Succinic Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-02-11 | — | — | US | disclosed |
| US-9180316-B2 | Butyric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-9162083-B2 | Linoleic and Linolenic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2015-10-20 | — | — | US | disclosed |
| US-20110250251-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | MAES DANIEL H | 2011-10-13 | — | — | US | disclosed |
| US-20100216879-A1 | Resveratrol Ferulate Compounds And Compositions | MAES DANIEL H | 2010-08-26 | — | — | US | disclosed |
| US-20100080845-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | MAES DANIEL H | 2010-04-01 | — | — | US | disclosed |
| US-20100028317-A1 | Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators | ELC MANAGEMENT LLC | 2010-02-04 | — | — | US | disclosed |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | ELC MANAGEMENT LLC | 2009-02-19 | — | — | US | disclosed |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | RB1, SIRT1, EP300 | CYP1A1 1440/4885KDM4E 506/4885MEN1 3365/4885 |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | SQLE, SMURF1, PIK3R1 | CYP1A1 2625/4885KDM4E 1188/4885MEN1 2323/4885 |
| US-20100216879-A1 | Resveratrol Ferulate Compounds And Compositions | FER, FOLR1, FOLR2 | CYP1A1 419/4885KDM4E 1158/4885MEN1 662/4885 |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | CUTA, ERCC1, OGG1 | CYP1A1 253/4885KDM4E 1584/4885MEN1 2434/4885 |
| US-20100028317-A1 | Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators | CRY1, PER2, SIRT1 | CYP1A1 1738/4885KDM4E 583/4885MEN1 1609/4885 |
| US-20110250251-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | CUTA, ERCC1, OGG1 | CYP1A1 253/4885KDM4E 1584/4885MEN1 2434/4885 |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | CUTA, SUV39H1, RARA | CYP1A1 348/4885KDM4E 450/4885MEN1 1277/4885 |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | SMURF1, CUTA, SMURF2 | CYP1A1 2419/4885KDM4E 1074/4885MEN1 2619/4885 |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | CUTA, LRAT, RARA | CYP1A1 1737/4885KDM4E 1813/4885MEN1 2973/4885 |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | SMARCC1, RARG, RARA | CYP1A1 1950/4885KDM4E 2286/4885MEN1 1807/4885 |
| US-20100080845-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | CUTA, ERCC1, OGG1 | CYP1A1 253/4885KDM4E 1584/4885MEN1 2434/4885 |
| US-20160229791-A1 | Malic Acid Esters Of Resveratrol And Cosmetic Compositions | ME1, ME2, ME3 | CYP1A1 786/4885KDM4E 421/4885MEN1 925/4885 |
| US-20160038389-A1 | Succinic Acid Esters Of Resveratrol And Cosmetic Compositions | SUCNR1, SIRT1, SUCLA2 | CYP1A1 1271/4885KDM4E 368/4885MEN1 2813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.